Chronic kidney disease (CKD) triggers the risk of developing uremic cardiomyopathy as
characterized by cardiac hypertrophy, fibrosis and functional impairment. Traditionally …

The cardiorenal syndrome (CRS) is described as a multi‐organ disease encompassing
bidirectionally heart and kidney. In CRS type 4, chronic kidney disease (CKD) leads to …

Uremic cardiomyopathy is responsible for high morbidity and mortality rates among patients
with chronic kidney disease (CKD), but the underlying mechanisms contributing to this …

Patients with advanced chronic kidney disease (CKD) mostly die from sudden cardiac death
and recurrent heart failure. The mechanisms of cardiac remodeling are largely unclear. To …

Heart failure is a major cause of morbidity and mortality in chronic kidney disease (CKD).
Rather than merely secondary to traditional vascular factors, CKD is also an independent …

Aims Patients with chronic kidney disease (CKD) have an increased risk of cardiovascular
events and exhibit myocardial changes including left ventricular (LV) hypertrophy and …

Cardiac remodeling occurs frequently in chronic kidney disease patients and affects quality
of life and survival. Current treatment options are highly inadequate. As kidney function …

Chronic kidney disease is often complicated by uremic cardiomyopathy that consists of left
ventricular hypertrophy and interstitial fibrosis. It is thought that hypertension and volume …

Cardiovascular disease constitutes the leading cause of mortality in patients with chronic
kidney disease (CKD) and end-stage renal disease. Despite increasing recognition of a …

Chronic kidney disease (CKD) affects millions of people globally and, for most patients, the
risk of developing cardiovascular disease is higher than that of progression to kidney failure …